Izervay versus Syfovre: Two Rivals Recently Approved for Management of Geographic Atrophy

Ann Afr Med. 2024 Jul 1;23(3):523-524. doi: 10.4103/aam.aam_186_23. Epub 2024 Jul 20.
No abstract available

Publication types

  • Letter

MeSH terms

  • Geographic Atrophy* / drug therapy
  • Humans
  • Treatment Outcome